About Lucid Diagnostics, Inc. 
Lucid Diagnostics, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 17 Schemes (8.39%)
Foreign Institutions
Held by 17 Foreign Institutions (0.51%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
1 Million
(Quarterly Results - Mar 2026)
Net Profit:
-14 Million
Pharmaceuticals & Biotechnology
USD 198 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.90
-450.59%
18.12






